RLAY - Relay Therapeutics EPS misses by $5.03 August, 27 2020 06:56 AM Relay Therapeutics Inc. Relay Therapeutics (NASDAQ:RLAY): Q2 GAAP EPS of -$6.06 misses by $5.03.Cash, cash equivalents and investments totaled $312M as of June 30, 2020 $312MPress ReleaseMore news on: Relay Therapeutics, Inc., Earnings news and commentary,